| Literature DB >> 16458521 |
Ana Cristina Lima Leite1, Renata Souza de Lima, Diogo Rodrigo de M Moreira, Marcos Veríssimo de O Cardoso, Ana Carolina Gouveia de Brito, Luciene Maria Farias Dos Santos, Marcelo Zaldini Hernandes, Alice Costa Kiperstok, Ricardo Santana de Lima, Milena B P Soares.
Abstract
A novel series of thiosemicarbazone and aminoacyl-thiazolidones derivatives were synthesized. Their structure suggests that these compounds could have anti-Trypanosoma cruzi activity. Biological evaluation indicates that some of these compounds are able to inhibit the growth of T. cruzi in concentrations non-cytotoxic to mammalian cells. Docking studies were carried out in order to investigate the binding pattern of these compounds for the T. cruzi cruzain (TCC) protein, and these showed a significant correlation with experimental data.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16458521 DOI: 10.1016/j.bmc.2006.01.034
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641